These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 39342741)
1. Computational modeling of tumor invasion from limited and diverse data in Glioblastoma. Jonnalagedda P; Weinberg B; Min TL; Bhanu S; Bhanu B Comput Med Imaging Graph; 2024 Oct; 117():102436. PubMed ID: 39342741 [TBL] [Abstract][Full Text] [Related]
2. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution. Kim JY; Gatenby RA Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831 [TBL] [Abstract][Full Text] [Related]
4. DC-AL GAN: Pseudoprogression and true tumor progression of glioblastoma multiform image classification based on DCGAN and AlexNet. Li M; Tang H; Chan MD; Zhou X; Qian X Med Phys; 2020 Mar; 47(3):1139-1150. PubMed ID: 31885094 [TBL] [Abstract][Full Text] [Related]
5. Generative adversarial network for glioblastoma ensures morphologic variations and improves diagnostic model for isocitrate dehydrogenase mutant type. Park JE; Eun D; Kim HS; Lee DH; Jang RW; Kim N Sci Rep; 2021 May; 11(1):9912. PubMed ID: 33972663 [TBL] [Abstract][Full Text] [Related]
7. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278 [TBL] [Abstract][Full Text] [Related]
8. Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma. Beig N; Bera K; Prasanna P; Antunes J; Correa R; Singh S; Saeed Bamashmos A; Ismail M; Braman N; Verma R; Hill VB; Statsevych V; Ahluwalia MS; Varadan V; Madabhushi A; Tiwari P Clin Cancer Res; 2020 Apr; 26(8):1866-1876. PubMed ID: 32079590 [TBL] [Abstract][Full Text] [Related]
9. Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas. Szeto MD; Chakraborty G; Hadley J; Rockne R; Muzi M; Alvord EC; Krohn KA; Spence AM; Swanson KR Cancer Res; 2009 May; 69(10):4502-9. PubMed ID: 19366800 [TBL] [Abstract][Full Text] [Related]
10. Metabolic and transcriptomic profiles of glioblastoma invasion revealed by comparisons between patients and corresponding orthotopic xenografts in mice. Cudalbu C; Bady P; Lai M; Xin L; Gusyatiner O; Hamou MF; Lepore M; Brouland JP; Daniel RT; Hottinger AF; Hegi ME Acta Neuropathol Commun; 2021 Aug; 9(1):133. PubMed ID: 34348785 [TBL] [Abstract][Full Text] [Related]
11. Image-driven modeling of the proliferation and necrosis of glioblastoma multiforme. Patel V; Hathout L Theor Biol Med Model; 2017 May; 14(1):10. PubMed ID: 28464925 [TBL] [Abstract][Full Text] [Related]
12. Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction. Zhou M; Chaudhury B; Hall LO; Goldgof DB; Gillies RJ; Gatenby RA J Magn Reson Imaging; 2017 Jul; 46(1):115-123. PubMed ID: 27678245 [TBL] [Abstract][Full Text] [Related]
14. Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma. Kong DS; Kim J; Lee IH; Kim ST; Seol HJ; Lee JI; Park WY; Ryu G; Wang Z; Ma'ayan A; Nam DH Oncotarget; 2016 Mar; 7(10):11526-38. PubMed ID: 26863628 [TBL] [Abstract][Full Text] [Related]
15. Radiogenomic classification for MGMT promoter methylation status using multi-omics fused feature space for least invasive diagnosis through mpMRI scans. Qureshi SA; Hussain L; Ibrar U; Alabdulkreem E; Nour MK; Alqahtani MS; Nafie FM; Mohamed A; Mohammed GP; Duong TQ Sci Rep; 2023 Feb; 13(1):3291. PubMed ID: 36841898 [TBL] [Abstract][Full Text] [Related]
16. Radiogenomics-Based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance. Qian X; Tan H; Liu X; Zhao W; Chan MD; Kim P; Zhou X Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927654 [TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging and deoxyribonucleic acid methylation-based radiogenomic models for survival risk stratification of glioblastoma. Zhang W; Yan Z; Peng J; Zhao S; Ran L; Yin H; Zhong D; Yang J; Ye J; Xu S Med Biol Eng Comput; 2024 Mar; 62(3):853-864. PubMed ID: 38057447 [TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme. Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472 [TBL] [Abstract][Full Text] [Related]
19. Quantitative volumetric assessment of baseline enhancing tumor volume as an imaging biomarker predicts overall survival in patients with glioblastoma. Auer TA; Della Seta M; Collettini F; Chapiro J; Zschaeck S; Ghadjar P; Badakhshi H; Florange J; Hamm B; Budach V; Kaul D Acta Radiol; 2021 Sep; 62(9):1200-1207. PubMed ID: 32938221 [TBL] [Abstract][Full Text] [Related]
20. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma. Cui Y; Ren S; Tha KK; Wu J; Shirato H; Li R Eur Radiol; 2017 Sep; 27(9):3583-3592. PubMed ID: 28168370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]